Showing 2,665 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

Costs for Hepatitis C Treatment Skyrocket

Editor's pick
Medscape (requires registration)
14 November 2013
Organ transplants

Congress Votes To End The Outdated Ban On HIV Organ Transplants And Research

Editor's pick
ThinkProgress
13 November 2013
Hepatitis & HIV

Faldaprevir plus pegylated interferon/ribavirin leads to early sustained response in people with HIV and HCV co-infection

News
13 November 2013
Hepatitis C treatment

Daclatasvir + asunaprevir cures 85% of genotype 1b hepatitis C patients in Japanese study

News
12 November 2013
New & experimental hepatitis C treatment

How Much? A Battle Over The Cost Of The New Hepatitis C Drugs

Editor's pick
Pharmalot
12 November 2013
New & experimental hepatitis C treatment

Fixed-dose sofosbuvir/ledipasvir with or without ribavirin cures most genotype 1 hepatitis C patients, LONESTAR study shows

News
11 November 2013
Hepatitis C treatment

Sofosbuvir taken before or after liver transplant reduces hepatitis C recurrence

News
8 November 2013
Hepatitis B

Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk

News
6 November 2013
New & experimental hepatitis C treatment

Sofosbuvir + ribavirin produces sustained response in 76% of genotype 1 HIV/HCV co-infected people

News
6 November 2013
Hepatitis C treatment

Simeprevir + sofosbuvir produces high sustained response rates for hard-to-treat patients in COSMOS trial

News
5 November 2013
New & experimental hepatitis C treatment

Hepatitis C, a Silent Killer, Meets Its Match

Editor's pick
New York Times
5 November 2013
New & experimental hepatitis C treatment

BMS interferon-free combination cures over 90% of genotype 1 hepatitis C in 12 weeks

News
5 November 2013
New & experimental hepatitis C treatment

Merck interferon-free combination shows high hepatitis C cure rate in early study

News
4 November 2013
Hepatitis C symptoms & diagnosis

Need for expansion of hepatitis C screening among veterans, 'baby-boom' generation and pregnant women highlighted

News
4 November 2013
New & experimental hepatitis C treatment

AbbVie’s two-drug, interferon-free combination cures genotype 1b hepatitis C infection in 95%

News
4 November 2013
New & experimental hepatitis C treatment

High response rates with telaprevir triple therapy for HIV-positive men with acute hepatitis C

News
4 November 2013
New & experimental hepatitis C treatment

In ELECTRON trial, 100% of hard-to-treat patients cured with sofosbuvir/ledipasvir plus ribavirin or GS-9669

News
4 November 2013
New & experimental hepatitis C treatment

Gilead Announces Phase 2 Results for Sofosbuvir-Based Regimens in Hepatitis C Patients Before and After Liver Transplantation

Editor's pick
Gilead press release
3 November 2013
New & experimental hepatitis C treatment

Gilead Announces New Sustained Viral Response Data for Sofosbuvir-Based Regimens in Genotype 3-Infected Hepatitis C Patients

Editor's pick
Gilead press release
3 November 2013
New & experimental hepatitis C treatment

Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising Phase II data

Editor's pick
Boehringer Ingelheim
3 November 2013
New & experimental hepatitis C treatment

High cure rates seen with Merck oral hepatitis drugs - study

Editor's pick
Reuters
3 November 2013
Hepatitis C treatment

Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant

Editor's pick
Eurekalert Medicine & Health
1 November 2013
Hepatitis C treatment

Studies: Current hepatitis C treatments can't be used by more than half of patients; others lose opportunity for treatment

Editor's pick
Eurekalert Medicine & Health
1 November 2013
New & experimental hepatitis C treatment

Idenix provides HCV pipeline update

Editor's pick
Idenix press release
1 November 2013